Is UGRO Capital (UGROCAP) overvalued or fairly valued?

MarketChacha shows UGRO Capital's valuation in context — a forward P/E of about 5.3, a price-to-book of about 0.5 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is UGRO Capital's revenue?

UGRO Capital reported revenue of ₹938 Cr for FY2026, with net profit of ₹113 Cr, per official filings.

What is the share price of UGRO Capital (UGROCAP)?

UGRO Capital last traded at ₹94.90 (-3.0% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

UGRO Capital

UGROCAP · NSE · NBFC · India

₹94.90-3.0%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 10:00 AM

Snapshot

TickerUGROCAP

ExchangeNSE

SectorNBFC

IndustryCredit Services

CountryIndia

CEOMr. Anuj Pandey

Employees2,095

HeadquartersMumbai, India

Market cap₹1,450 Cr

P/B0.5

Volume1.45L

Websitewww.ugrocapital.com

Filings tracked0

About UGRO Capital

UGRO Capital Limited, a non-banking financial company, engages in the lending business in India. The company offers business loans to healthcare, education, chemicals, food processing/FMCG, hospitality, electrical equipment and components, auto components, textile, micro enterprises, and light engineering sectors. It also provides lending services for enterprise mortgages, school funding programs, machinery and equipment financing, and supply chain finance. In addition, it offers embedded finance; retailer and rooftop solar financing; electric vehicle financing; and loans against property and bank guarantee services. The company was formerly known as Chokhani Securities Limited and changed its name to UGRO Capital Limited in September 2018. The company was incorporated in 1993 and is based in Mumbai, India.

Profile as reported by Yahoo Finance.

Who owns it

Promoters47.3%
Institutions14.0%
Public & other38.8%

7 institutional holders

As reported by Yahoo Finance. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

Margin has compressed by about 6.6 points over the period — profitability is trending down.

Net margin trend18.7% → 12.1%

Margin has compressed by about 6.6 points over the period — profitability is trending down.

Growth qualityrev 21% · PAT 42%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (Yahoo Finance). Education, not a rating or recommendation.

What's expected next

Next fiscal year

Rev ₹1,286 Cr · EPS 17.90

Est. earnings growth +21.0%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

₹80.1252-wk range₹192.50

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: Yahoo Finance

Annual

Quarterly · last 4

Market cap

₹1,450 Cr

Day change

-3.0%

Fwd P/E

5.3

P/B

0.5

Beta

0.24

Revenue (FY2026)

₹938 Cr

Net margin

12.1%

Revenue CAGR (2y)

+21.2%

Profit CAGR (3y)

+41.8%

Net profit (FY2026)

₹113 Cr

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about UGROCAP

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	Net margin
FY2026	₹938 Cr	₹113 Cr	12.1%
FY2025	₹814 Cr	₹144 Cr	17.7%
FY2024	₹639 Cr	₹119 Cr	18.7%
FY2023	—	₹40 Cr	—

Quarterly

Period	Revenue	Net profit	Net margin
2026Q1	—	₹30 Cr	—
2025Q4	—	₹6 Cr	—
2025Q3	—	₹43 Cr	—
2025Q2	₹216 Cr	₹34 Cr	15.8%

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.